Colon cancer blood test offers new screening option
Time:2024-05-21 11:42:32 Source:worldViews(143)
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Previous:Everybody may love Raymond, but Ray Romano loves Peter Boyle
Next:Georgia Republicans choose Amy Kremer, organizer of pro
You may also like
- Jessica Biel CHOPS her long locks into a bob after book signing in Studio City
- Moment two bears grapple with each other in remarkable scrap captured on camera in national park
- Participant, film studio behind 'Spotlight,’ shutters after 20 years
- The push for school choice in Nebraska is pitting lawmakers against their constituents
- Here comes the char
- NHL announces Bodyarmor as its new sports drink, replacing BioSteel
- Liz Truss accuses government of 'finger
- Facing a Republican revolt, House Speaker Johnson pushes ahead on US aid for Ukraine, allies
- Analysis: Larson enters conversation with Verstappen as best drivers in the world